Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BT5528 |
Trade Name | |
Synonyms | BT-5528 |
Drug Descriptions |
BT5528 is a bicyclic peptide targeting Epha2 in conjugation with a cytotoxin, which may specifically target Epha2-expressing tumor cells (Cancer Res 2018;78(13 Suppl):Abstract nr 5854, PMID: 32398269). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C171425 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BT5528 | BT5528 | 0 | 1 |
BT5528 + Nivolumab | BT5528 Nivolumab | 0 | 1 |